Status:
RECRUITING
Transpacific TAVR Registry
Lead Sponsor:
Duk-Woo Park, MD
Collaborating Sponsors:
CardioVascular Research Foundation, Korea
Conditions:
Heart Valve Diseases
Aortic Valve Insufficiency
Eligibility:
All Genders
19+ years
Brief Summary
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
Detailed Description
This study is connected with Asian TAVR registry(NCT02308150). Some subjects from Asian TAVR registry continue 10 years follow-up on this TP-TAVR registry.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All patients undergoing TAVR
- Informed consent
Exclusion
Key Trial Info
Start Date :
June 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2036
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03826264
Start Date
June 15 2019
End Date
December 31 2036
Last Update
January 2 2026
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305
2
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611
3
Second Affiliated Hospital of Zhejiang University
Hangzhou, China
4
Bucheon Sejong Hospital
Bucheon-si, South Korea